Results 71 to 80 of about 16,086 (104)

Hepatocellular carcinoma drug resistance models. [PDF]

open access: yesCancer Cell Int
Xie X   +5 more
europepmc   +1 more source

Fluvastatin suppresses breast cancer initiation and progression via targeting CYP4Z1. [PDF]

open access: yesCommun Biol
Li H   +12 more
europepmc   +1 more source

A ketogenic diet sensitizes pancreatic cancer to glutamine metabolism inhibitors. [PDF]

open access: yesCell Rep Med
Hajihassani O   +34 more
europepmc   +1 more source

The VAX2-SERPINE1 axis modulates colorectal cancer cell proliferation and apoptosis through WNT/beta-catenin signaling. [PDF]

open access: yesTransl Oncol
Zhang J   +18 more
europepmc   +1 more source

The IGF2BP3-FASN axis drives lipid metabolic reprogramming to promote brain colonization in non-small cell lung cancer. [PDF]

open access: yesCell Death Dis
Li J   +14 more
europepmc   +1 more source

Luteinizing Hormone-Releasing Hormone (LHRH)-Targeted Treatment in Ovarian Cancer. [PDF]

open access: yesInt J Mol Sci
Nayak P   +5 more
europepmc   +1 more source

Aqueous Dispersion of Unmodified Fullerene C60: Stimulation of Hair Growth and Study of a New Molecular Target for Interaction. [PDF]

open access: yesInt J Mol Sci
Shershakova N   +12 more
europepmc   +1 more source

An EGFR co-amplified lncRNA HELDR promotes glioblastoma malignancy through KAT7-driven gene programs. [PDF]

open access: yesNat Cell Biol
Yu X   +11 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy